描述 |
Ondansetron盐酸盐是5-HT3受体拮抗剂,可作为化疗后止吐剂。 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
溶解度 |
体外:
在DMSO中10mM
|
||||||||||||
储备液 |
|
||||||||||||
存储 |
请将产品存放在分析证书中的建议条件下。
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
O=C1C(CN2C=CN=C2C)CCC(N3C)=C1C4=C3C=CC=C4.[H]Cl |
||||||||||||
参考文献 |
|
||||||||||||
相关活性 小分子 |
肉叶云香碱 | 2-胺基-5-(4-硝基苯磺酰)-噻唑 | 5-羟基色胺盐酸盐 | 3-甲氧基-4-羟基肉桂酸钠 | 盐酸硫利达嗪 | 依匹哌唑 | 利培酮 | TG6-10-1 | 卡利拉嗪 | 喹硫平 | 舍吲哚 | 1-(o-烯丙基苯氧基)-3-(异丙基氨基)-2-丙醇 盐酸盐 | 盐酸他利克索 | 凯他色林 | 盐酸帕洛诺司琼 |
密度 | 1.27g/cm3 |
---|---|
沸点 | 546?C at 760mmHg |
熔点 | 178.5-179.5?C |
分子式 | C18H20ClN3O |
分子量 | 329.824 |
闪点 | 284?C |
精确质量 | 329.129486 |
PSA | 39.82000 |
LogP | 3.93050 |
外观性状 | 白色粉末 |
储存条件 | ?20°C |
水溶解性 | H2O: >5?mg/mL |
危害码 (欧洲) |
T: Toxic; |
---|---|
风险声明 (欧洲) |
R25 |
安全声明 (欧洲) |
45-37/39-26 |
危险品运输编码 | UN 2811 6 |
WGK德国 | 3 |
RTECS号 | FE6375500 |
包装等级 | II |
危险类别 | 6.1(a) |
海关编码 | 29339900 |
~90%
盐酸枢复宁
99614-01-4
|
文献:WO2005/37822 A1, ; Page/Page column 12 ; |
~78%
盐酸枢复宁
99614-01-4
|
文献:WO2005/37822 A1, ; Page/Page column 12 ; |
~93%
盐酸枢复宁
99614-01-4
|
文献:YUHAN CORPORATION Patent: ? WO2005/37822?A1, 2005 ; Location in patent: Page/Page column 12 ; |
盐酸枢复宁上游产品? 4 | |
---|---|
|
|
盐酸枢复宁下游产品? 2 | |
|
UNII:2999F27MAD |
(R)-Ondansetron Hydrochloride Dihydrate |
4H-CARBAZOL-4-ONE,1,2,3,9-TETRAHYDRO-9-METHYL-3-[(2-METHYL-1H-IMIDAZOL-1-YL)METHYL]-,HYDROCHLORIDE (1:1) |
9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one |
LSUREMONOETHANOLAMID |
Ondansetron HCl |
1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one hydrochloride |
OEA,oleoylethanolamide |
N-(Hydroxyethyl)oleamide |
9-Methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride |
[3H]-Oleoylethanolamide |
oleic acid ethanolamide |
ONDANSETRON HCL DIHYDRATE |
9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4h-carbazol-4-onhydrochlorid |
Ondansetron HCl (Zofran) |
4H-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-, monohydrochloride |
oleic monoethanolamide |
Ondansetron (hydrochloride) |
ONDANSETRONHYDROCHLORIDE |
ONDANSETRON HCL DIHYDRATE IMP. E (EP): 1H-IMIDAZOLE, CRM STANDARD |
Ondansetron hydrochloride (Zofran) |
oleic acid-N-monoethanolamide |
N-(2-Hydroxyethyl)oleamide |
OEA |
Oleoylethanolamide |
[3H]-Ondansetron hydrochloride |
4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-, hydrochloride (1:1) |
ODANSETRON HYDROCHLORIDE DIHYDRATE |
Ondansetron Hydrochloride |
Oleyl monoethanolamide |
OLEAMIDE MEA |
9-méthyl-3-[(2-méthyl-1H-imidazol-1-yl)méthyl]-1,2,3,9-tétrahydro-4H-carbazol-4-one chlorhydrate |
Oleoylmonoethanolamide |
9-Methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride (1:1) |